
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.930 | 2.930 | 0.000 |
Shares | 97.070 | 97.070 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.324 | 19.611 |
Price to Book | 3.064 | 3.844 |
Price to Sales | 1.958 | 2.221 |
Price to Cash Flow | 12.429 | 14.840 |
Dividend Yield | 1.868 | 1.499 |
5 Years Earnings Growth | 9.868 | 10.202 |
Number of long holdings: 50
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
J&J | US4781601046 | 8.00 | 163.70 | +0.44% | |
AstraZeneca | GB0009895292 | 7.46 | 10,294.0 | -0.17% | |
Roche Holding Participation | CH0012032048 | 6.35 | 258.50 | +0.58% | |
Eli Lilly | US5324571083 | 6.15 | 771.71 | +1.34% | |
Lonza Group | CH0013841017 | 5.39 | 569.80 | -0.04% | |
UnitedHealth | US91324P1021 | 4.63 | 282.65 | -1.88% | |
Pfizer | US7170811035 | 4.53 | 24.47 | -0.45% | |
Vertex | US92532F1003 | 4.14 | 459.81 | -0.75% | |
Horizon Therapeutics PLC | IE00BQPVQZ61 | 3.96 | - | - | |
Thermo Fisher Scientific | US8835561023 | 3.89 | 414.75 | -2.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NO0010827280 | 121.96B | -5.85 | 15.39 | 12.02 | ||
NO0010827819 | 83.57B | 2.29 | 23.91 | 20.11 | ||
NO0012740200 | 5.2B | -8.55 | 16.68 | 14.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review